ACE2 and colorectal carcinoma: This supports the potential of ‘RAS-modulating combinations’ in CRC treatment and suggests that polyphenols (e.g., EGCG, resveratrol) could either replace or augment vitamin D in such therapeutic regimens due to their shared capacity to upregulate ACE2.